US Patent 8048430 Influenza hemagglutinin and neuraminidase variants
Patent 8048430 was granted and assigned to MedImmune on November, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+157 characters)
Article
Patent abstract
Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Chin-Fen Yang0
Chongguang Liu0
George Kemble0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08048430 Influenza hemagglutinin and neuraminidase variants US Patent 8048430 Influenza hemagglutinin and neuraminidase variants
Infobox
Patent Number
08048430
Patent Number
8048430
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08048430 Influenza hemagglutinin and neuraminidase variants
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08048430
Date of patent
November 1, 2011
Patent application number
12877000
Date Filed
September 7, 2010
Patent primary examiner
Find more entities like US Patent 8048430 Influenza hemagglutinin and neuraminidase variants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
